Global Engineered T Cells Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Engineered T Cells Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Engineered T Cells Market Size Growth Rate by Product
  • 1.4.2 Tumor Infiltrating Lymphocytes
  • 1.4.3 T Cell Receptor {TCR}
  • 1.4.4 Chimeric Antigen Receptor (CAR)
• 1.5 Market by End User
  • 1.5.1 Global Engineered T Cells Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Cancer Research Centers
  • 1.5.4 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Engineered T Cells Market Size
  • 2.1.1 Global Engineered T Cells Revenue 2014-2025
  • 2.1.2 Global Engineered T Cells Sales 2014-2025
• 2.2 Engineered T Cells Growth Rate by Regions
  • 2.2.1 Global Engineered T Cells Sales by Regions
  • 2.2.2 Global Engineered T Cells Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Engineered T Cells Sales by Manufacturers
  • 3.1.1 Engineered T Cells Sales by Manufacturers
  • 3.1.2 Engineered T Cells Sales Market Share by Manufacturers
  • 3.1.3 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
• 3.2 Engineered T Cells Revenue by Manufacturers
  • 3.2.1 Engineered T Cells Revenue by Manufacturers (2014-2019)
  • 3.2.2 Engineered T Cells Revenue Share by Manufacturers (2014-2019)
• 3.3 Engineered T Cells Price by Manufacturers
• 3.4 Engineered T Cells Manufacturing Base Distribution, Product Types
  • 3.4.1 Engineered T Cells Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Engineered T Cells Product Type
  • 3.4.3 Date of International Manufacturers Enter into Engineered T Cells Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Engineered T Cells Sales by Product
• 4.2 Global Engineered T Cells Revenue by Product
• 4.3 Engineered T Cells Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Engineered T Cells Breakdown Data by End User

6 North America

• 6.1 North America Engineered T Cells by Countries
  • 6.1.1 North America Engineered T Cells Sales by Countries
  • 6.1.2 North America Engineered T Cells Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Engineered T Cells by Product
• 6.3 North America Engineered T Cells by End User

7 Europe

• 7.1 Europe Engineered T Cells by Countries
  • 7.1.1 Europe Engineered T Cells Sales by Countries
  • 7.1.2 Europe Engineered T Cells Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Engineered T Cells by Product
• 7.3 Europe Engineered T Cells by End User

8 Asia Pacific

• 8.1 Asia Pacific Engineered T Cells by Countries
  • 8.1.1 Asia Pacific Engineered T Cells Sales by Countries
  • 8.1.2 Asia Pacific Engineered T Cells Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Engineered T Cells by Product
• 8.3 Asia Pacific Engineered T Cells by End User

9 Central & South America

• 9.1 Central & South America Engineered T Cells by Countries
  • 9.1.1 Central & South America Engineered T Cells Sales by Countries
  • 9.1.2 Central & South America Engineered T Cells Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Engineered T Cells by Product
• 9.3 Central & South America Engineered T Cells by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Engineered T Cells by Countries
  • 10.1.1 Middle East and Africa Engineered T Cells Sales by Countries
  • 10.1.2 Middle East and Africa Engineered T Cells Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Engineered T Cells by Product
• 10.3 Middle East and Africa Engineered T Cells by End User

11 Company Profiles

• 11.1 Autolus Limited
  • 11.1.1 Autolus Limited Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Autolus Limited Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Autolus Limited Engineered T Cells Products Offered
  • 11.1.5 Autolus Limited Recent Development
• 11.2 Bellicum Pharmaceuticals
  • 11.2.1 Bellicum Pharmaceuticals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bellicum Pharmaceuticals Engineered T Cells Products Offered
  • 11.2.5 Bellicum Pharmaceuticals Recent Development
• 11.3 Cells Medica
  • 11.3.1 Cells Medica Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Cells Medica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Cells Medica Engineered T Cells Products Offered
  • 11.3.5 Cells Medica Recent Development
• 11.4 Elli Lilly and Company
  • 11.4.1 Elli Lilly and Company Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Elli Lilly and Company Engineered T Cells Products Offered
  • 11.4.5 Elli Lilly and Company Recent Development
• 11.5 Gilead Sciences
  • 11.5.1 Gilead Sciences Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Gilead Sciences Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Gilead Sciences Engineered T Cells Products Offered
  • 11.5.5 Gilead Sciences Recent Development
• 11.6 Juno Therapeutics
  • 11.6.1 Juno Therapeutics Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Juno Therapeutics Engineered T Cells Products Offered
  • 11.6.5 Juno Therapeutics Recent Development
• 11.7 Novartis
  • 11.7.1 Novartis Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Novartis Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Novartis Engineered T Cells Products Offered
  • 11.7.5 Novartis Recent Development
• 11.8 Oxford Biomedica
  • 11.8.1 Oxford Biomedica Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Oxford Biomedica Engineered T Cells Products Offered
  • 11.8.5 Oxford Biomedica Recent Development
• 11.9 Pfizer
  • 11.9.1 Pfizer Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Pfizer Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Pfizer Engineered T Cells Products Offered
  • 11.9.5 Pfizer Recent Development
• 11.10 Precision Bioscience
  • 11.10.1 Precision Bioscience Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Precision Bioscience Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Precision Bioscience Engineered T Cells Products Offered
  • 11.10.5 Precision Bioscience Recent Development
• 11.11 Redmile Group
• 11.12 Seeking Alpha
• 11.13 Unum Therapeutics

12 Future Forecast

• 12.1 Engineered T Cells Market Forecast by Regions
  • 12.1.1 Global Engineered T Cells Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Engineered T Cells Revenue Forecast by Regions 2019-2025
• 12.2 Engineered T Cells Market Forecast by Product
  • 12.2.1 Global Engineered T Cells Sales Forecast by Product 2019-2025
  • 12.2.2 Global Engineered T Cells Revenue Forecast by Product 2019-2025
• 12.3 Engineered T Cells Market Forecast by End User
• 12.4 North America Engineered T Cells Forecast
• 12.5 Europe Engineered T Cells Forecast
• 12.6 Asia Pacific Engineered T Cells Forecast
• 12.7 Central & South America Engineered T Cells Forecast
• 12.8 Middle East and Africa Engineered T Cells Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Engineered T Cells Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details